Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03873844 · ClinicalTrials.gov registry record · NA
Improving Thinking in Everyday Life: Pilot Study A
A NA study of Cognitive Impairment, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03873844: Completed NA study of Cognitive Impairment, sponsored by University of Alabama at Birmingham.
NCT03873844 is a NA study of Cognitive Impairment that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 6 participants, below the 666-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03873844, a NA study of Cognitive Impairment, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study at the University of Alabama at Birmingham. The purpose of this initial study is to test how effective a new therapy is for improving participants ability to think, particularly how rapidly they process information that they receive from their senses, e.g., sight, hearing,… . The study will also test whether the new therapy improves how often and how well they are able to carry out tasks that rely on thinking in their daily life. The therapy will combine a computer game that ask participants to identify targets on the screen as rapidly as possible with a set of psychological techniques that will help to apply the improvements that are made in how rapidly participants process information as a result of the game to carrying out tasks that rely on thinking in your daily life.
Primary Outcome
The CTAL collects information about attempts by the participant to complete activities of daily living (ADL) and instrumental ADL (IADL).
Conditions Studied
Interventions
- BEHAVIORAL Speed of Processing Training
- BEHAVIORAL Transfer Package from CI Therapy
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT03873844 record still lists
NCT03873844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 666-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Speed of Processing Training is the first listed.
NCT03873844 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03873844 about?
NCT03873844 is a clinical study titled "Improving Thinking in Everyday Life: Pilot Study A". This is a pilot study at the University of Alabama at Birmingham. The purpose of this initial study is to test how effective a new therapy is for improving participants ability to think, particularly how rapidly they process information that they receive from their senses, e.g., sight, hearing,… . T...
What is the current status of trial NCT03873844?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-04-01. Estimated completion is 2022-06-30.
What conditions does trial NCT03873844 study?
This clinical trial studies the following conditions: Cognitive Impairment.
What interventions are being tested in trial NCT03873844?
The interventions under investigation include: Speed of Processing Training (BEHAVIORAL), Transfer Package from CI Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03873844?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03873844 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03873844's enrollment target sits among peer trials
6 106th of 105 the lowest of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI